Zacks Investment Management »

Atea Pharmaceuticals shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $80k 24k 3.35